Vertex Pharmaceuticals Inc. Reports Rise In Q4 Profit

Vertex Pharmaceuticals Inc. (VRTX) reported earnings for its fourth quarter that increased from the same period last year

The company's earnings came in at $818.9 million, or $3.15 per share. This compares with $770.1 million, or $3.00 per share, in last year's fourth quarter.

Excluding items, Vertex Pharmaceuticals Inc. reported adjusted earnings of $978.0 million or $3.76 per share for the period.

The company's revenue for the quarter rose 11.1% to $2.30 billion from $2.07 billion last year.

Vertex Pharmaceuticals Inc. earnings at a glance (GAAP) :

-Earnings (Q4): $818.9 Mln. vs. $770.1 Mln. last year.
-EPS (Q4): $3.15 vs. $3.00 last year.
-Revenue (Q4): $2.30 Bln vs. $2.07 Bln last year.

For comments and feedback contact: editorial@rttnews.com

Follow RTT